Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Global Blood Therapeutics, Inc. (GBT)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/06/2022 |
4
| PERRY MARK L (Director) has filed a Form 4 on Global Blood Therapeutics, Inc.|
Txns:
| Disposed/sold 37,865 shares
@ $0
Disposed/sold 3,600 restricted stock units
@ $0
Disposed/sold 15,000 options to buy
@ $42.25, valued at
$633.8k
Disposed/sold 7,500 options to buy
@ $56.3, valued at
$422.3k
Disposed/sold 5,247 options to buy
@ $64.75, valued at
$339.7k
Disposed/sold 5,600 options to buy
@ $37.09, valued at
$207.7k
Disposed/sold 5,600 options to buy
@ $22.3, valued at
$124.9k
|
|
| 10/06/2022 |
4
| PATRICK DEVAL L (Director) has filed a Form 4 on Global Blood Therapeutics, Inc.|
Txns:
| Disposed/sold 9,037 shares
@ $0
Disposed/sold 3,600 restricted stock units
@ $0
Disposed/sold 625 options to buy
@ $68.75, valued at
$43k
Disposed/sold 5,247 options to buy
@ $64.75, valued at
$339.7k
Disposed/sold 5,600 options to buy
@ $37.09, valued at
$207.7k
Disposed/sold 5,600 options to buy
@ $22.3, valued at
$124.9k
|
|
| 10/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/06/2022 |
4
| YARNO WENDY L (Director) has filed a Form 4 on Global Blood Therapeutics, Inc.|
Txns:
| Disposed/sold 11,437 shares
@ $0
Disposed/sold 3,600 restricted stock units
@ $0
Disposed/sold 30,000 options to buy
@ $38.55, valued at
$1.2M
Disposed/sold 15,000 options to buy
@ $42.25, valued at
$633.8k
Disposed/sold 7,500 options to buy
@ $56.3, valued at
$422.3k
Disposed/sold 5,247 options to buy
@ $64.75, valued at
$339.7k
Disposed/sold 5,600 options to buy
@ $37.09, valued at
$207.7k
Disposed/sold 5,600 options to buy
@ $22.3, valued at
$124.9k
|
|
| 10/06/2022 |
4
| Pizzo Philip A. (Director) has filed a Form 4 on Global Blood Therapeutics, Inc.|
Txns:
| Disposed/sold 9,112 shares
@ $0
Disposed/sold 3,600 restricted stock units
@ $0
Disposed/sold 15,000 options to buy
@ $42.25, valued at
$633.8k
Disposed/sold 7,500 options to buy
@ $56.3, valued at
$422.3k
Disposed/sold 5,247 options to buy
@ $64.75, valued at
$339.7k
Disposed/sold 5,600 options to buy
@ $37.09, valued at
$207.7k
Disposed/sold 5,600 options to buy
@ $22.3, valued at
$124.9k
Disposed/sold 30,000 options to buy
@ $46.49, valued at
$1.4M
|
|
| 10/06/2022 |
4
| Svoronos Dawn (Director) has filed a Form 4 on Global Blood Therapeutics, Inc.|
Txns:
| Disposed/sold 5,376 shares
@ $0
Disposed/sold 3,600 restricted stock units
@ $0
Disposed/sold 30,000 options to buy
@ $38.68, valued at
$1.2M
Disposed/sold 7,500 options to buy
@ $56.3, valued at
$422.3k
Disposed/sold 5,247 options to buy
@ $64.75, valued at
$339.7k
Disposed/sold 5,600 options to buy
@ $37.09, valued at
$207.7k
Disposed/sold 5,600 options to buy
@ $22.3, valued at
$124.9k
|
|
| 10/06/2022 |
4
| PIERCE GLENN (Director) has filed a Form 4 on Global Blood Therapeutics, Inc.|
Txns:
| Disposed/sold 26,437 shares
@ $0
Disposed/sold 3,600 restricted stock units
@ $0
Disposed/sold 15,000 options to buy
@ $15.03, valued at
$225.5k
Disposed/sold 15,000 options to buy
@ $18.85, valued at
$282.8k
Disposed/sold 15,000 options to buy
@ $28.45, valued at
$426.8k
Disposed/sold 15,000 options to buy
@ $42.25, valued at
$633.8k
Disposed/sold 7,500 options to buy
@ $56.3, valued at
$422.3k
Disposed/sold 5,247 options to buy
@ $64.75, valued at
$339.7k
Disposed/sold 5,600 options to buy
@ $37.09, valued at
$207.7k
Disposed/sold 5,600 options to buy
@ $22.3, valued at
$124.9k
|
|
| 10/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/06/2022 |
4
| LOVE TED W (President and CEO) has filed a Form 4 on Global Blood Therapeutics, Inc.|
Txns:
| Disposed/sold 576,318 shares
@ $0
Disposed/sold 119,650 shares
@ $0
Disposed/sold 102,000 shares
@ $0
Disposed/sold 2,500 shares
@ $0
Disposed/sold 11,250 restricted stock units
@ $0
Disposed/sold 26,865 restricted stock units
@ $0
Disposed/sold 47,223 restricted stock units
@ $0
Disposed/sold 63,768 restricted stock units
@ $0
Disposed/sold 109,116 restricted stock units
@ $0
Disposed/sold 141,400 restricted stock units
@ $0
Disposed/sold 114,515 options to buy
@ $16.4, valued at
$1.9M
|
|
| 10/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/06/2022 |
4
| Farrow Jeffrey S (CFO) has filed a Form 4 on Global Blood Therapeutics, Inc.|
Txns:
| Disposed/sold 26,739 shares
@ $0
Disposed/sold 3,125 restricted stock units
@ $0
Disposed/sold 9,060 restricted stock units
@ $0
Disposed/sold 13,814 restricted stock units
@ $0
Disposed/sold 15,460 restricted stock units
@ $0
Disposed/sold 26,454 restricted stock units
@ $0
Disposed/sold 42,400 restricted stock units
@ $0
Disposed/sold 120,000 options to buy
@ $14.96, valued at
$1.8M
Disposed/sold 10,299 options to buy
@ $16.4, valued at
$168.9k
Disposed/sold 35,000 options to buy
@ $59.6, valued at
$2.1M
Disposed/sold 40,000 options to buy
@ $48.44, valued at
$1.9M
|
|
| 10/06/2022 |
4
| SUVARI TRICIA BORGA (Chief Legal Officer) has filed a Form 4 on Global Blood Therapeutics, Inc.|
Txns:
| Disposed/sold 43,077 shares
@ $0
Disposed/sold 3,125 restricted stock units
@ $0
Disposed/sold 9,060 restricted stock units
@ $0
Disposed/sold 13,814 restricted stock units
@ $0
Disposed/sold 15,460 restricted stock units
@ $0
Disposed/sold 26,454 restricted stock units
@ $0
Disposed/sold 42,400 restricted stock units
@ $0
Disposed/sold 100,000 options to buy
@ $18.25, valued at
$1.8M
Disposed/sold 40,000 options to buy
@ $59.6, valued at
$2.4M
Disposed/sold 40,000 options to buy
@ $48.44, valued at
$1.9M
Disposed/sold 38,500 options to buy
@ $65.82, valued at
$2.5M
|
|
| 10/04/2022 |
4
| Habibizad Nazila (See Remarks) has filed a Form 4 on Global Blood Therapeutics, Inc.|
Txns:
| Gifted 3,500 shares
@ $0
Exercised 1,375 restricted stock units
@ $0
Exercised 182 restricted stock units
@ $0 |
|
| 09/29/2022 |
4
| Farrow Jeffrey S (CFO) has filed a Form 4 on Global Blood Therapeutics, Inc.|
Txns:
| Exercised 23,653 options to buy
@ $16.4, valued at
$387.9k
|
|
| 09/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/29/2022 |
4
| LOVE TED W (President and CEO) has filed a Form 4 on Global Blood Therapeutics, Inc.|
Txns:
| Gifted 221,200 shares
@ $0
Gifted 35,300 shares
@ $0
Gifted 17,650 shares
@ $0
Exercised 18,291 options to buy
@ $16.4, valued at
$300k
|
|
| 09/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/06/2022 |
4
| Habibizad Nazila (See Remarks) has filed a Form 4 on Global Blood Therapeutics, Inc.|
Txns:
| Granted 414 shares
@ $25.37, valued at
$10.5k
Paid exercise price by delivering 1,342 shares
@ $68.15, valued at
$91.5k
Exercised 1,670 restricted stock units
@ $0
Exercised 2,208 restricted stock units
@ $0 |
|
| 09/06/2022 |
4
| JOHNSON DAVID LEE (Chief Commercial Officer) has filed a Form 4 on Global Blood Therapeutics, Inc.|
Txns:
| Granted 365 shares
@ $25.37, valued at
$9.3k
Paid exercise price by delivering 2,103 shares
@ $68.15, valued at
$143.3k
Exercised 2,763 restricted stock units
@ $0
Exercised 2,208 restricted stock units
@ $0 |
|
| 09/06/2022 |
4
| Smith-Whitley Kim (See Remarks) has filed a Form 4 on Global Blood Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 607 shares
@ $68.15, valued at
$41.4k
Exercised 2,208 restricted stock units
@ $0 |
|
| 09/06/2022 |
4
| Krehlik Carrie (Chief Human Resources Officer) has filed a Form 4 on Global Blood Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 3,552 shares
@ $68.15, valued at
$242.1k
Exercised 8,060 restricted stock units
@ $0
Exercised 2,208 restricted stock units
@ $0 |
|
| 09/06/2022 |
4
| LOVE TED W (President and CEO) has filed a Form 4 on Global Blood Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 9,200 shares
@ $68.15, valued at
$627k
Exercised 9,444 restricted stock units
@ $0
Exercised 9,109 restricted stock units
@ $0 |
|
| 09/06/2022 |
4
| Farrow Jeffrey S (CFO) has filed a Form 4 on Global Blood Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 1,885 shares
@ $68.15, valued at
$128.5k
Sold 31,441 shares
@ $68, valued at
$2.1M
Exercised 2,763 restricted stock units
@ $0
Exercised 2,208 restricted stock units
@ $0 |
|
| 09/06/2022 |
4
| Choi Jung (See Remarks) has filed a Form 4 on Global Blood Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 1,861 shares
@ $68.15, valued at
$126.8k
Exercised 2,763 restricted stock units
@ $0
Exercised 2,208 restricted stock units
@ $0 |
|
| 09/06/2022 |
4
| SUVARI TRICIA BORGA (Chief Legal Officer) has filed a Form 4 on Global Blood Therapeutics, Inc.|
Txns:
| Granted 385 shares
@ $25.37, valued at
$9.8k
Paid exercise price by delivering 1,881 shares
@ $68.15, valued at
$128.2k
Exercised 2,763 restricted stock units
@ $0
Exercised 2,208 restricted stock units
@ $0 |
|
| 08/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/03/2022 |
4
| SUVARI TRICIA BORGA (Chief Legal Officer) has filed a Form 4 on Global Blood Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 2,126 shares
@ $32.4, valued at
$68.9k
Exercised 3,125 restricted stock units
@ $0
Exercised 3,020 restricted stock units
@ $0 |
|
| 08/03/2022 |
4
| Habibizad Nazila (See Remarks) has filed a Form 4 on Global Blood Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 526 shares
@ $32.4, valued at
$17k
Exercised 937 restricted stock units
@ $0
Exercised 581 restricted stock units
@ $0 |
|
| 08/03/2022 |
4
| LOVE TED W (President and CEO) has filed a Form 4 on Global Blood Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 10,018 shares
@ $32.4, valued at
$324.6k
Exercised 11,250 restricted stock units
@ $0
Exercised 8,955 restricted stock units
@ $0 |
|
| 08/03/2022 |
4
| Choi Jung (See Remarks) has filed a Form 4 on Global Blood Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 2,126 shares
@ $32.4, valued at
$68.9k
Exercised 3,125 restricted stock units
@ $0
Exercised 3,020 restricted stock units
@ $0 |
|
|
|
|